PFIZER REPORTS FIRST-QUARTER 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
May 1, 2018 6:47 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.15 billion.
Reaffirmed All Components of 2018 Financial Guidance:
Revenues: $53.5 to $55.5 billionAdjusted Diluted EPS: $2.90 to $3.
For earnings history and earnings-related data on Pfizer (PFE) click here.
... More